Office-based buprenorphine treatment; Board of Medicine to amend regulations.
1
What it does
Official summary
Board of Medicine; office-based buprenorphine treatment; counseling. Directs the Board of Medicine to amend its regulations regarding office-based buprenorphine treatment to require providers to offer counseling or referral to counseling to each patient as clinically necessary and mutually agreed-upon. The bill specifies that a patient's refusal of counseling does not preclude the patient from receiving office-based buprenorphine treatment for opioid use disorder.
More detail
This bill is a recommendation of the Joint Commission on Health Care and is identical to SB 641.
2
Where do you stand?
Choose your position
3
Tell your reps
Take a position to see your representatives and ways to contact them.
4
More on this bill
Where it stands
Introduced
Passed House
Passed Senate
To Governor
Became Law
Looking ahead
No hearings or votes scheduled.
History
2026
Apr 6Acts of Assembly Chapter text (CHAP0207)Latest